Regulatory Show all
May 27 | 2024

Revised Financial Calendar Announcement

Read more
May 7 | 2024

2CUREX AB (PUBL) HAS DECIDED TO APPLY FOR A DELISTING OF ITS SHARES ON NASDAQ FIRST NORTH GROWTH MARKET IN STOCKHOLM – EXPECTED LAST DAY OF TRADING BY END OF JUNE

Read more
March 16 | 2024

2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS

Read more
February 29 | 2024

KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
February 29 | 2024

BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)

Read more
February 22 | 2024

2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024

Read more
February 12 | 2024

KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
February 12 | 2024

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)

Read more
January 4 | 2024

2cureX announces changes to the Board of Directors.

Read more
December 29 | 2023

2cureX announces changes to the management

Read more
December 6 | 2023

2cureX Receives Ethical Approval for Groundbreaking HIPEC Clinical Trial

Read more
November 23 | 2023

2cureX publishes interim report for the third quarter of 2023

Read more
November 14 | 2023

KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMAN I 2CUREX AB (PUBL)

Read more
November 14 | 2023

BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)

Read more
November 10 | 2023

IndiTreat® Image Uploader gets IVD CE-Mark

Read more
October 30 | 2023

2cureX participated in “Knæk Cancer” panel discussion.

Read more
October 26 | 2023

Strategy update: Leapfrogging to the decentralization of IndiTreat® testing through full focus on automation

Read more
October 25 | 2023

KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more